Zenith Drugs Complete Financial Statements
ZENITHDRUG • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2024 - 2022
Complete Financial Data Export
Export complete financial statements for Zenith Drugs (ZENITHDRUG).
Downloads include all available records across all periods.
For market performance, see the
ZENITHDRUG stock price today
.
Profitability Ratios
Net Profit Margin
7.46%
2024 data
EBITDA Margin
14.18%
2024 data
Operating Margin
13.00%
2024 data
Return on Assets
7.41%
2024 data
Return on Equity
16.13%
2024 data
Balance Sheet Ratios
Current Ratio
12.56
2024 data
Debt to Equity
2.18
2024 data
Equity Ratio
45.93%
2024 data
Asset Turnover
0.99
2024 data
Year-over-Year Growth Analysis
Comparing March 2024 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+37.8%
Year-over-Year
Equity Growth
+244.4%
Year-over-Year
Liabilities Growth
+37.8%
Year-over-Year
Operating Cash Flow Growth
-160.0%
Year-over-Year
Financing Cash Flow Growth
-200.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Revenue | 0 | 134 | 116 | 93 |
| Expenses | 0 | 115 | 106 | 85 |
| EBITDA | 0 | 19 | 10 | 8 |
| Operating Profit Margin % | 0.00% | 13.00% | 8.00% | 7.00% |
| Depreciation | 0 | 1 | 1 | 1 |
| Interest | 0 | 3 | 2 | 2 |
| Profit Before Tax | 0 | 13 | 7 | 4 |
| Tax | 0 | 4 | 2 | 1 |
| Net Profit | 0 | 10 | 5 | 3 |
| Earnings Per Share (₹) | 0.00 | 5.63 | 122.02 | 78.22 |
Related Pages for Zenith Drugs
Additional stock information and data for ZENITHDRUG
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2024 | 2023 | 2022 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 135 | 98 | 69 |
| Current Assets | 113 | 84 | 54 |
| Fixed Assets | 11 | 12 | 11 |
| Capital Work in Progress | 4 | 0 | 3 |
| Investments | 0 | 0 | 0 |
| Other Assets | 120 | 86 | 55 |
| LIABILITIES | |||
| Total Liabilities | 135 | 98 | 69 |
| Current Liabilities | 9 | 9 | 10 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 62 | 18 | 12 |
| Share Capital | 17 | 0 | 0 |
| Reserves & Surplus | 45 | 17 | 12 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2024 | March 2023 | March 2022 |
|---|---|---|---|
| Operating Activities | -13 | -5 | 5 |
| Investing Activities | 26 | 0 | -5 |
| Financing Activities | -5 | 5 | 1 |
| Net Cash Flow | 9 | 0 | 1 |